Why Was Nifedipine Taken Off the Market? The Immediate-Release Formulation Controversy
•
3 min read
The use of short-acting, immediate-release (IR) nifedipine for hypertensive emergencies was largely abandoned following 1990s medical literature and FDA warnings that exposed significant safety risks. This led to the misconception that **why was nifedipine taken off the market** entirely, when in fact, the more stable extended-release (ER) versions remain available and are widely used today.
